Issue Price
₹50
Per Share
GMP
NIL
Grey Market
Est. Listing
₹50
Expected Price
Min. Application
₹300,000
2 lots × 3000 shares
Incorporated in 2004, Sakar Healthcare Ltd is a manufacturer of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsules, Dry Powder Syrup, Liquid Injectables (SVP) in Ampoules and Vials & Dry Powder Injections for leading Multinational pharmaceutical companies.Sakar Healthcare an ISO 9001:2008 BVQI certified company.Sakar has presence in more than 40 countries and is growing as the exports of pharmaceutical products from India to the developed countries.
Sakar Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 153,000 | — | ₹0.77 Cr | — |
| TOTAL | 2,961,000 | 100.00% | ₹14.81 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹150,000 |
| Retail (Max) | 13 | 39,000 | ₹1,950,000 |
| sNII (Min) | 14 | 42,000 | ₹2,100,000 |
| bNII (Min) | 68 | 204,000 | ₹10,200,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |